

universities who allegedly have failed to disclose foreign affiliations on their grant applications," his letter states. Now, some details have emerged from Levinson's response to Grassley's request to detail the steps his office is taking "to protect the integrity of medical research from foreign threats." The 12 recent referrals, for example, "appear to primarily involve Principal Investigators on NIH grants conducting medical research at U.S. NIH and HHS officials also suggested they were investigating about a half-dozen cases in which agency-funded investigators may have broken reporting rules, although they were vague about the details or scope of their review. In August 2018, such concerns led NIH to send a letter to more than 10,000 research institutions, urging them to ensure that NIH grantees are properly reporting their foreign ties. It responds to a series of questions posed in a 17 January letter from Grassley, chairman of the Senate Committee on Finance and one of many members of Congress who have raised concerns that China and other nations are exploiting U.S.-funded research for their own benefit. The 31 January letter, released yesterday by Senator Chuck Grassley (R–IA), is signed by HHS Inspector General (IG) Daniel Levinson. (HHS also oversees other research agencies, including the Centers for Disease Control and Prevention.) In both cases, the Department of Justice declined to file civil or criminal charges. Neither of those cases appears to have involved NIH.


The letter also discloses that over the past 5 years, investigators at the Department of Health and Human Services (HHS), NIH's parent agency, referred two cases to prosecutors that involved federally funded scientists who allegedly failed to disclose foreign ties or stole intellectual property. universities who allegedly failed to disclose foreign affiliations on their grant proposals. The letter reveals that the National Institutes of Health (NIH) in Bethesda, Maryland, recently asked federal investigators to review 12 allegations of rule violations, mostly involving researchers at U.S. government effort to scrutinize federally funded biomedical research for potentially problematic foreign involvement. A newly released letter from a government watchdog has shed a little light on an ongoing U.S.
